Nautilus Biotechnology Inc (NAUT) Stock Price, Quote & News

Company Profile

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprising instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 333 2001

Website: www.nautilus.bio

Address:

2701 Eastlake Avenue East, Seattle, United States

Omega_Proxy Aug. 19 at 4:55 PM

$NAUT Amazon has had a stake for a long time, correct? 1 million is nothing to Amazon anyway, right?

0 · Reply

Dr24stock Aug. 6 at 12:21 PM

How dead can u be? $NAUT: yes.

0 · Reply

Rebooter Aug. 5 at 11:03 PM

$NAUT Bezos is straight up chasing, throwing good money after bad in a desperate attempt to salvage the worst investment he's ever made. Spoiler alert, throwing a measly $1 million at Theranos 2.0 isn't going to push it above $1.

1 · Reply

Chuckyboss1 Aug. 5 at 10:42 PM

$NAUT the market is so screwed up they owned those shares for 10 years

0 · Reply

Dr24stock Aug. 5 at 9:39 PM

$NAUT meanwhile...

1 · Reply

Dr24stock Aug. 5 at 9:34 PM

$NAUT Amazon bought in is the news.

1 · Reply

scottredler Aug. 5 at 9:04 PM

AMAZON $AMZN JUST FILED ITS 13F — HERE’S WHAT IT’S HOLDING: $AMD, $ALAB, $IONQ, $MRVL, $NAUT, $OWLT, $RIVN, $VITL, $SMRT

1 · Reply

Aburose Aug. 5 at 8:43 PM

$NAUT Nautilus Biotechnology Q2 2025 EPS $(0.12) Beats $(0.15) Estimate. very good just hold maysee over 5-6 soon

2 · Reply

premarketmaker Aug. 5 at 8:36 PM

$NAUT if you are in, keep tight stops .83 support

0 · Reply

premarketmaker Aug. 5 at 8:34 PM

$NAUT see nothing 58M float

1 · Reply

Nautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call Transcript

Jul 31, 2025, 8:00 AM EDT - 19 days ago

Nautilus Biotechnology Reports Second Quarter 2025 Financial Results

Jul 15, 2025, 8:00 AM EDT - 5 weeks ago

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

Apr 29, 2025, 1:01 PM EDT - 4 months ago

Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript

Feb 28, 2025, 6:59 PM EST - 6 months ago

Nautilus: Trading Below An Albeit Lower Net Cash Figure

Feb 28, 2025, 7:25 AM EST - 6 months ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 9:50 AM EST - 6 months ago

Nautilus Biotechnology layoffs 16% of workforce, plans release of commercial platform in 2026

Oct 31, 2024, 8:00 AM EDT - 10 months ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award

Oct 30, 2024, 8:00 AM EDT - 10 months ago

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

Oct 29, 2024, 1:17 PM EDT - 10 months ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript

Jul 30, 2024, 3:16 PM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

Apr 30, 2024, 1:19 PM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

Feb 28, 2024, 1:13 PM EST - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:00 AM EST - 1 year ago

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 22, 2024, 8:00 AM EST - 1 year ago

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

Feb 7, 2024, 8:00 AM EST - 1 year ago

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Nov 30, 2023, 8:00 AM EST - 1 year ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Nov 1, 2023, 8:05 AM EDT - 1 year ago

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Oct 31, 2023, 11:22 AM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 8:05 AM EDT - 1 year ago

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

Oct 11, 2023, 8:05 AM EDT - 2 years ago

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

Aug 4, 2023, 8:00 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

Aug 2, 2023, 1:33 PM EDT - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 7:30 AM EDT - 2 years ago

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

Jul 11, 2023, 9:23 AM EDT - 2 years ago

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

May 24, 2023, 8:05 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

May 2, 2023, 6:30 AM EDT - 2 years ago

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

Apr 18, 2023, 4:05 PM EDT - 2 years ago

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

Mar 23, 2023, 8:00 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

Feb 25, 2023, 3:09 PM EST - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Call Transcript

Feb 23, 2023, 6:05 AM EST - 2 years ago

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Feb 21, 2023, 8:00 AM EST - 2 years ago

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

Jan 26, 2023, 8:00 AM EST - 2 years ago

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Jan 26, 2023, 7:45 AM EST - 2 years ago

Nautilus Biotechnology Expands to San Diego

Jan 19, 2023, 8:00 AM EST - 2 years ago

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

Dec 27, 2022, 10:53 AM EST - 2 years ago

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

Nov 1, 2022, 2:35 PM EDT - 3 years ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript

Nov 1, 2022, 6:05 AM EDT - 3 years ago

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

Sep 23, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

Sep 1, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

Aug 30, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

Aug 2, 2022, 12:02 PM EDT - 3 years ago

Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q2 2022 Results - Earnings Call Transcript

Aug 2, 2022, 6:48 AM EDT - 3 years ago

Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

Jul 13, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

May 3, 2022, 12:21 PM EDT - 3 years ago

Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q1 2022 Results - Earnings Call Transcript

May 3, 2022, 6:00 AM EDT - 3 years ago

Nautilus Biotechnology Reports First Quarter 2022 Financial Results

Omega_Proxy Aug. 19 at 4:55 PM

$NAUT Amazon has had a stake for a long time, correct? 1 million is nothing to Amazon anyway, right?

0 · Reply

Dr24stock Aug. 6 at 12:21 PM

How dead can u be? $NAUT: yes.

0 · Reply

Rebooter Aug. 5 at 11:03 PM

1 · Reply

Chuckyboss1 Aug. 5 at 10:42 PM

$NAUT the market is so screwed up they owned those shares for 10 years

0 · Reply

Dr24stock Aug. 5 at 9:39 PM

$NAUT meanwhile...

1 · Reply

Dr24stock Aug. 5 at 9:34 PM

$NAUT Amazon bought in is the news.

1 · Reply

scottredler Aug. 5 at 9:04 PM

AMAZON $AMZN JUST FILED ITS 13F — HERE’S WHAT IT’S HOLDING: $AMD, $ALAB, $IONQ, $MRVL, $NAUT, $OWLT, $RIVN, $VITL, $SMRT

1 · Reply

Aburose Aug. 5 at 8:43 PM

$NAUT Nautilus Biotechnology Q2 2025 EPS $(0.12) Beats $(0.15) Estimate. very good just hold maysee over 5-6 soon

2 · Reply

premarketmaker Aug. 5 at 8:36 PM

$NAUT if you are in, keep tight stops .83 support

0 · Reply

premarketmaker Aug. 5 at 8:34 PM

$NAUT see nothing 58M float

1 · Reply

jabroni1111 Aug. 5 at 8:33 PM

$NAUT

0 · Reply

premarketmaker Aug. 5 at 8:32 PM

$NAUT be cautious - I see no news trying to locate

0 · Reply

Rebooter Aug. 4 at 8:24 PM

$NAUT Shareholders, you're facing one of two options. Either 300% dilution or a reverse split. Pick your poison, but the final outcome is most assuredly the same either way.

1 · Reply

d_risk Aug. 1 at 1:55 PM

$NAUT - Nautilus Biotechnolgy Inc. Common Stock - 10Q - Updated Risk Factors NAUT’s 10-Q updates risk factors with expanded intellectual property litigation and ownership disputes, new FDA and data privacy regulatory risks, intensified cybersecurity threats, supply chain and geopolitical challenges, heightened stock volatility and delisting risks, plus new governance, tax, and growth management concerns. #Biotechnology #SupplyChain #Cybersecurity #RegulatoryRisks #IntellectualProperty 🟢 Added 🟠 Removed https://d-risk.ai/NAUT/10-Q/2025-07-31

0 · Reply

mhaven2020 Jul. 25 at 2:30 PM

$ARDX was hoping for a better week than that. Sold 60% of my position. Still expecting 5.50 after earnings (probably the week after) but my money can work harder somewhere else during that time. Perhaps $WLDS or $WRAP. Maybe $NAUT or $RAY. Researching....

2 · Reply

mhaven2020 Jul. 25 at 2:29 PM

0 · Reply

MGeronimo Jul. 25 at 1:29 PM

$NAUT ADDED AT .75 looking for a bounce back off support

0 · Reply

Bellbent Jul. 24 at 3:47 PM

$SSKN $PLRX $NAUT $QSI In biogem we trust!

0 · Reply

Bellbent Jul. 24 at 2:16 PM

$QSI Still crossing my fingers on a 1.20 entry! Made great money flipping $NAUT and $PLRX as of late. Currently hifing in $SSKN all thanks to @BioGem

0 · Reply

Will2ride1 Jul. 18 at 3:42 PM

$NAUT taking some down here

0 · Reply

WHO905 Jul. 10 at 5:08 PM

$NAUT Something is fundamentally wrong here that branches beyond latency in time to market. The technology likely doesn’t work; which would render their IP worthless. The company has $1.10 cash on hand per share and yet it is trading at .77. Will be very difficult to get the credibility of The Street.

1 · Reply

Rebooter Jul. 10 at 4:21 PM

$NAUT Ten cents off all time low. Four straight months below $1 with reverse split on the horizon. Best case, product launch still two years away. Burning through cash with no means of raising additional capital. The words 'death spiral' come to mind.

0 · Reply

Market Cap	90.01M
Revenue (ttm)	0.00
Net Income (ttm)	-70.78M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	255,357
Avg Vol	343,814
Day's Range	N/A - N/A
Shares Out	126.31M
Stochastic %K	12%
Beta	1.42
Analysts	Strong Sell
Price Target	$2.50